CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Coherus Biosciences, Inc. v. Amgen Inc.

1:19-cv-00139

Overview

Case Number 1:19-cv-00139
Filing Date 2019-01-24
Status Terminated
Termination Date 2019-11-26
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Amgen Inc. Operating Company

Represented By

3 Attorneys Listed

Brian P. Egan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9454

1201 North Market Street, P.O. Box 1347

Joseph E. Lasher

UNDELIVERABLE EMAIL 1/28/2020

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Plaintiff

Coherus Biosciences, Inc. Operating Company

Represented By

2 Attorneys Listed

William Chad Shear

Fish & Richardson, P.C.

Tel: +1 (858) 678-5070

12390 El Camino Real, San Diego, CA 92130

Robert M. Oakes

Fish & Richardson, P.C.

Tel: +1 (302) 778-8477

222 Delaware Avenue, 17th Floor, P.O. Box 1114

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 1 proceeding
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (1 found):
PTAB: 1
USPTO PTAB Trial 2019-09-17
PGR2019-00064

Fresenius Kabi USA, LLC et al. v. Coherus BioSciences, Inc.

U.S. Continuation Sibling (10155039)
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US10155039
Stable aqueous formulations of adalimumab
Filed: 2017-10-31
Issued: 2018-12-18
Active (10.9 yrs remaining)
Expires: 2037-10-31
US10159732
Stable aqueous formulations of adalimumab
Filed: 2017-10-05
Issued: 2018-12-25
Active (10.9 yrs remaining)
Expires: 2037-10-05
US10159733
Stable aqueous formulations of adalimumab
Filed: 2017-10-05
Issued: 2018-12-25
Active (10.9 yrs remaining)
Expires: 2037-10-05
US10207000
Stable aqueous formulations of adalimumab
Filed: 2017-10-05
Issued: 2019-02-19
Active (10.9 yrs remaining)
Expires: 2037-10-05

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

26

Dispositive

0

Granted

0

Denied

0

Pending / Review

13

Motions by Category

Procedural / Extension Motion 25 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED re 65 STIPULATION and Proposed Order to Extend Time (*Reset Briefing Schedule: re 55 MOTION for a Determination of Exceptional Case and an Award of F...
Entry #β€” • 2020-01-10
Procedural / Extension Motion Pending / Under Review
STIPULATION and Proposed Order to Extend Time - filed by Amgen Inc.. (Blumenfeld, Jack) Modified on 1/10/2020 (nms). (Entered: 01/09/2020)
Entry #65 • 2020-01-09 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to file opposition to motion to January 7, 2020 - filed by Coherus Biosciences, Inc.. (Oakes, Robert) (Entered: 12/11/2019)
Entry #58 • 2019-12-11 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 58 STIPULATION TO EXTEND TIME to file opposition to motion to January 7, 2020 (*Reset Briefing Schedule: re 55 MOTION for a Determination of Exce...
Entry #β€” • 2019-12-11
Procedural / Extension Motion Pending
SO ORDERED, re 51 STIPULATION TO EXTEND TIME for Amgen Inc. to serve its initial invalidity contentions and prior art to November 25, 2019. Signed by Judge Rich...
Entry #β€” • 2019-11-25
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Amgen Inc. to serve its initial invalidity contentions and prior art to November 25, 2019 - filed by Coherus Biosciences, Inc.. (...
Entry #51 • 2019-11-22 Document →

Docket Entries

(146 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Amgen Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2552429.) - filed by Coherus Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Civil Cover Sheet)(nmg) (Entered: 01/25/2019)

Entry #1 • 2019-01-24
1
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Amgen Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2552429.) - filed by Coherus Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Civil Cover Sheet)(nmg) (Entered: 01/25/2019)

Entry #1 • 2019-01-24
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Amgen Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2552429.) - filed by Coherus Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Civil Cover Sheet)(nmg) (Entered: 01/25/2019)

Entry #1 • 2019-01-24
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Amgen Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2552429.) - filed by Coherus Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Civil Cover Sheet)(nmg) (Entered: 01/25/2019)

Entry #1 • 2019-01-24
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Amgen Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2552429.) - filed by Coherus Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Civil Cover Sheet)(nmg) (Entered: 01/25/2019)

Entry #1 • 2019-01-24
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc